7-135134965-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_178563.4(AGBL3):c.2467C>T(p.Pro823Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000213 in 1,551,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_178563.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGBL3 | NM_178563.4 | c.2467C>T | p.Pro823Ser | missense_variant | 17/17 | ENST00000436302.6 | NP_848658.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGBL3 | ENST00000436302.6 | c.2467C>T | p.Pro823Ser | missense_variant | 17/17 | 2 | NM_178563.4 | ENSP00000388275 | P2 | |
CYREN | ENST00000459937.5 | n.356+33784G>A | intron_variant, non_coding_transcript_variant | 1 | ||||||
AGBL3 | ENST00000435976.6 | c.2111-12848C>T | intron_variant | 5 | ENSP00000401220 | A2 | ||||
CYREN | ENST00000464070.1 | n.187+13012G>A | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152018Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000130 AC: 2AN: 153736Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 81560
GnomAD4 exome AF: 0.0000200 AC: 28AN: 1399026Hom.: 0 Cov.: 31 AF XY: 0.0000159 AC XY: 11AN XY: 690034
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152018Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74256
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 08, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at